CMK Corporation
CMK Corporation (6958.T) Financial Performance & Income Statement Overview
Review CMK Corporation (6958.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
CMK Corporation (6958.T) Income Statement & Financial Overview
View the income breakdown for CMK Corporation 6958.T across both annual and quarterly reports.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $24.81B | $24.40B | $23.41B | $22.87B |
| Cost of Revenue | $20.78B | $20.46B | $19.43B | $19.25B |
| Gross Profit | $4.03B | $3.94B | $3.98B | $3.62B |
| Gross Profit Ratio | $0.16 | $0.16 | $0.17 | $0.16 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.04B | $2.89B | $2.98B | $2.85B |
| Operating Expenses | $3.04B | $2.89B | $2.96B | $2.87B |
| Total Costs & Expenses | $23.82B | $23.34B | $22.39B | $22.12B |
| Interest Income | $50.00M | $17.00M | $24.00M | $0.00 |
| Interest Expense | $242.00M | $0.00 | $101.00M | $0.00 |
| Depreciation & Amortization | $0.00 | $1.32B | $1.44B | $1.37B |
| EBITDA | $38.00M | $2.37B | $2.47B | $3.43B |
| EBITDA Ratio | $0.002 | $0.10 | $0.11 | $0.15 |
| Operating Income | $989.00M | $1.05B | $1.02B | $749.00M |
| Operating Income Ratio | $0.04 | $0.04 | $0.04 | $0.03 |
| Other Income/Expenses (Net) | -$1.16B | $909.00M | $563.00M | $1.22B |
| Income Before Tax | -$167.00M | $1.96B | $1.58B | $1.97B |
| Income Before Tax Ratio | -$0.007 | $0.08 | $0.07 | $0.09 |
| Income Tax Expense | $718.00M | -$199.00M | $401.00M | $523.00M |
| Net Income | -$920.00M | $2.11B | $1.17B | $1.43B |
| Net Income Ratio | -$0.04 | $0.09 | $0.05 | $0.06 |
| EPS | -$12.91 | $29.67 | $16.35 | $20.08 |
| Diluted EPS | -$12.91 | $29.67 | $16.35 | $20.08 |
| Weighted Avg Shares Outstanding | $71.25M | $71.25M | $71.24M | $71.23M |
| Weighted Avg Shares Outstanding (Diluted) | $71.25M | $71.25M | $71.24M | $71.23M |
Over the past four quarters, CMK Corporation demonstrated steady revenue growth, increasing from $22.87B in Q1 2025 to $24.81B in Q4 2025. Operating income reached $989.00M in Q4 2025, maintaining a consistent 4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $38.00M, reflecting operational efficiency. Net income dropped to -$920.00M, with EPS at -$12.91. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan